Cancer Clinical Investigation

88 Active
123 Finished

Administrative Core
Hirsch, F.
National Cancer Institute
30/09/22 → 31/08/23
Project: Research
Preclinical Validation of Novel Gut-Restricted LRRK2 Inhibitors as Therapeutic Leads for IBD
Peter, I. & DeVita, R.
National Institute of Diabetes and Digestive and Kidney Diseases
30/09/22 → 30/06/23
Project: Research
Mechanistic understanding of dysregulated iron metabolism in polycythemia vera
Ginzburg, Y. & Hoffman, R.
National Institute of Diabetes and Digestive and Kidney Diseases
20/09/22 → 31/08/23
Project: Research
Admin-Core-001
Garcia-Sastre, A. & Hirsch, F.
National Cancer Institute
1/09/22 → 31/08/23
Project: Research
High resolution molecular imaging to elucidate the contextual mechanisms of BCG resistance in non-muscle invasive recurrent bladder cancer
Sfakianos, J.
Bladder Cancer Advocacy Network
1/01/22 → 31/12/23
Project: Research
ASH Bridge Grant Award
Laganà, A.
American Society of Hematology
1/01/22 → …
Project: Research
Dissecting and targeting canonical and non-canonical oncogenic functions of EZH2 in cancer
Wang, G. G. G. G. & Jin, J.
National Cancer Institute
1/01/22 → 31/12/23
Project: Research
Elucidating the Molecular Mechanisms that Mediate DKD Progression in Patients Living with HIV
He, J. J. C. & Ma’ayan, A.
National Institute of Diabetes and Digestive and Kidney Diseases
1/12/21 → 30/11/23
Project: Research
A novel treatment option for disorders of propionate metabolism
Houten, S., DeVita, R., Houten, S. M. & Devita, R. R. J.
National Institute of Child Health and Human Development
22/09/21 → 31/08/23
Project: Research
Comparative Modeling for the Prevention and Control of Uterine Cancer
Wright, J. J., Bickell, N., Blank, S., Kong, C. C., Elkin, E. E. B., Elkin, E. B., Havrilesky, L. J., Kong, C., Havrilesky, L. L. J., Bickell, N. N. A., Blank, S. S. V. & Wright, J.
National Cancer Institute
17/09/21 → 31/08/23
Project: Research
AN INTEGRATED PLATFORM FOR NOVEL PERSONALIZED LIVER CANCER THERAPEUTICS
Dar, A., Guccione, E., Lujambio, A., Guccione, E. E., Guccione, E. & Lujambio, A.
National Cancer Institute
1/07/21 → 30/06/23
Project: Research
Substrate reduction as a novel therapeutic strategy for Glutaric Aciduria Type 1
Houten, S., DeVita, R., Houten, S. M. & Devita, R. R. J.
National Institute of Child Health and Human Development
1/05/21 → 30/04/23
Project: Research

220227 Citations
199 h-index
2446 Article
541 Review article
129 Letter
122 Comment/debate
More

Applications of artificial intelligence in prostate cancer histopathology
Busby, D., Grauer, R., Pandav, K., Khosla, A., Jain, P., Menon, M., Haines, G. K., Cordon-Cardo, C., Gorin, M. A. & Tewari, A. K., 2023, (Accepted/In press) In: Urologic Oncology: Seminars and Original Investigations.
Research output: Contribution to journal › Review article › peer-review
Bridging advanced myeloma patients to subsequent treatments and clinical trials with classical chemotherapy and stem cell support
Mouhieddine, T. H., Moshier, E., Thibaud, S., Puliafito, B., Rattu, M., Jakubowski, R., Sanchez, L., Rossi, A., Rodriguez, C., Richard, S., Cho, H. J., Parekh, S., Chari, A., Steinberg, A. & Richter, J., Jan 2023, In: Bone Marrow Transplantation. 58, 1, p. 80-86 7 p.
Research output: Contribution to journal › Article › peer-review
Clinical and treatment characteristics of secondary bladder malignancies following low dose rate brachytherapy for prostate cancer
Chin, C. P., Smith, W. H., Cesaretti, J., Terk, M., Garden, E. B., Araya, J. S., Palese, M. A., Stock, R. G. & Buckstein, M., 2023, (Accepted/In press) In: Urologic Oncology: Seminars and Original Investigations.
Research output: Contribution to journal › Article › peer-review
Dietary iron restriction protects against vaso-occlusion and organ damage in murine sickle cell disease
Li, H., Kazmi, J. S., Lee, S., Zhang, D., Gao, X., Maryanovich, M., Torres, L., Verma, D., Kelly, L., Ginzburg, Y. Z., Frenette, P. S. & Manwani, D., 12 Jan 2023, In: Blood. 141, 2, p. 194-199 6 p.
Research output: Contribution to journal › Article › peer-review
1 Scopus citations
Erratum: Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements (Communications biology (2022) 5 1 (1295))
Kimmerling, R. J., Stevens, M. M., Olcum, S., Minnah, A., Vacha, M., LaBella, R., Ferri, M., Wasserman, S. C., Fujii, J., Shaheen, Z., Sundaresan, S., Ribadeneyra, D., Jayabalan, D. S., Agte, S., Aleman, A., Criscitiello, J. A., Niesvizky, R., Luskin, M. R., Parekh, S., Rosenbaum, C. A., & 2 othersTamrazi, A. & Reid, C. A., 6 Jan 2023, In: Communications Biology. 6, 1, p. 15 1 p.
Research output: Contribution to journal › Comment/debate

Open Access
Hits and Misses in Novel Pancreatic and Rectal Cancer Treatment Options
Chuong, M. D., Anker, C. J., Buckstein, M. H., Hawkins, M. A., Kharofa, J., Raldow, A. C., Sanford, N. N., Wojcieszysnki, A. & Olsen, J. R., 1 Mar 2023, In: International Journal of Radiation Oncology Biology Physics. 115, 3, p. 545-552 8 p.
Research output: Contribution to journal › Editorial
Outcomes Following SBRT vs. IMRT and 3DCRT for Older Patients with Stage IIA Node-Negative Non-Small Cell Lung Cancer > 5 cm
Tran, J. H., Mhango, G., Park, H. S., Marshall, D. C., Rosenzweig, K. E., Wang, Q., Wisnivesky, J. P. & Veluswamy, R. R., Jan 2023, In: Clinical Lung Cancer. 24, 1, p. e9-e18
Research output: Contribution to journal › Article › peer-review
Patient Perceptions Regarding Ciltacabtagene Autoleucel Treatment: Qualitative Evidence From Interviews With Patients With Relapsed/Refractory Multiple Myeloma in the CARTITUDE-1 Study
Cohen, A. D., Hari, P., Htut, M., Berdeja, J. G., Usmani, S. Z., Madduri, D., Olyslager, Y., Goldberg, J. D., Schecter, J. M., Jackson, C. C., Gries, K. S., Fastenau, J. M., Valluri, S., Deraedt, W., Akram, M., Crawford, R., Morrison, R., Doward, L., Morgan, K., Seldam, S. T., & 2 othersJakubowiak, A. & Jagannath, S., Jan 2023, In: Clinical Lymphoma, Myeloma and Leukemia. 23, 1, p. 68-77 10 p.
Research output: Contribution to journal › Article › peer-review

Open Access
Prolonged hypernutrition impairs TREM2-dependent efferocytosis to license chronic liver inflammation and NASH development
Wang, X., He, Q., Zhou, C., Xu, Y., Liu, D., Fujiwara, N., Kubota, N., Click, A., Henderson, P., Vancil, J., Marquez, C. A., Gunasekaran, G., Schwartz, M. E., Tabrizian, P., Sarpel, U., Fiel, M. I., Diao, Y., Sun, B., Hoshida, Y., Liang, S., & 1 othersZhong, Z., 10 Jan 2023, In: Immunity. 56, 1, p. 58-77.e11
Research output: Contribution to journal › Article › peer-review
1 Scopus citations
Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma Patients
Thompson, M. A., Boccadoro, M., Leleu, X., Vela-Ojeda, J., van Rhee, F., Weisel, K. C., Rifkin, R. M., Usmani, S. Z., Hájek, R., Cook, G., Abonour, R., Armour, M., Morgan, K. E., Yeh, S. P., Costello, C. L., Berdeja, J. G., Davies, F. E., Zonder, J. A., Lee, H. C., Omel, J., & 9 othersSpencer, A., Terpos, E., Hungria, V. T. M., Puig, N., Fu, C., Ferrari, R. H., Ren, K., Stull, D. M. & Chari, A., 2023, (Accepted/In press) In: Clinical Lymphoma, Myeloma and Leukemia.
Research output: Contribution to journal › Article › peer-review

Open Access
Recent Advances in the Use of Chimeric Antigen Receptor–Expressing T-Cell Therapies for Treatment of Multiple Myeloma: Clinically advanced CAR-T therapies for RRMM
Martin, T., Jackson, C. C., Pacaud, L., Madduri, D. & Jagannath, S., Jan 2023, In: Clinical Lymphoma, Myeloma and Leukemia. 23, 1, p. 22-27 6 p.
Research output: Contribution to journal › Short survey › peer-review
Side-specific, Microultrasound-based Nomogram for the Prediction of Extracapsular Extension in Prostate Cancer
Pedraza, A. M., Parekh, S., Joshi, H., Grauer, R., Wagaskar, V., Zuluaga, L., Gupta, R., Barthe, F., Nasri, J., Pandav, K., Patel, D., Gorin, M. A., Menon, M. & Tewari, A. K., Feb 2023, In: European Urology Open Science. 48, p. 72-81 10 p.
Research output: Contribution to journal › Article › peer-review

Open Access

Breast Cancer Expert Focuses on Decoding Biomarkers
Joseph Sparano
2/02/23
1 item of Media coverage
Press/Media
Clinical Review of ropeginterferon alfa-2b Suggests Amended Dosing Schedule May Support Improved Clinical Outcomes in Polycythemia Vera
John Mascarenhas
2/02/23
2 items of Media coverage
Press/Media
Woman, 36, details rare cervical cancer diagnosis while pregnant with 1st child
Marshall Posner
1/02/23
2 items of Media coverage
Press/Media
Cancer vaccines: Can the disease be treated with an injection?
Nina Bhardwaj
1/02/23
1 item of Media coverage
Press/Media
OVARIAN CANCER LEADERS URGE GENETIC TESTING FOR INCREASED-RISK INDIVIDUALS, AND CONSIDERATION OF PROPHYLACTIC SURGERY FOR ALL WOMEN
Stephanie Blank
1/02/23
59 items of Media coverage
Press/Media
Difficulty fitting family into career: Female oncologists
Stephanie Blank
31/01/23
2 items of Media coverage
Press/Media
Cell BioEngines Enters into Licensing Agreement with Icahn School of Medicine at Mount Sinai
Sreekumar Balanalan, Sreekumar Balan & Nina Bhardwaj
27/01/23
1 item of Media coverage
Press/Media
Dr. Goodman on the Use of SBRT in Locally Advanced Pancreatic Cancer
Karyn Goodman
27/01/23
1 item of Media coverage
Press/Media
New drugs, if approved, could have big impact in 2023
Ajai Chari
27/01/23
1 item of Media coverage
Press/Media
What Will Save Rural Healthcare?
Charles Powell
26/01/23
1 item of Media coverage
Press/Media
Cell BioEngines Enters into an Exclusive Worldwide Agreement to Develop and Commercialize Potent Immune Cell States to Cure Cancer
Sreekumar Balanalan, Sreekumar Balan & Nina Bhardwaj
25/01/23 → 26/01/23
93 items of Media coverage
Press/Media
A Tennis Champion Who is Also a Breast Cancer Survivor
Kenneth L. Davis & Hanna Irie
25/01/23
1 item of Media coverage
Press/Media